Cargando…
Exploration of KIR genes and hematological-related diseases in Chinese Han population
The function of natural killer (NK) cells has previously been implicated in hematopoietic-related diseases. Killer immunoglobulin-like receptors (KIR) play an important role in NK cells after hematopoietic stem cell transplantation. To explore the immunogenetic predisposition of hematological-relate...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276034/ https://www.ncbi.nlm.nih.gov/pubmed/37328612 http://dx.doi.org/10.1038/s41598-023-36882-y |
_version_ | 1785059990928621568 |
---|---|
author | Li, Ye-Mo Li, Yu-Xia Hu, Xiao-Zhuang Li, Dai-Yang An, Lin Yuan, Zhi-Yang Liu, Zhong-Liang Du, Ke-Ming Zheng, Zhong-Zheng |
author_facet | Li, Ye-Mo Li, Yu-Xia Hu, Xiao-Zhuang Li, Dai-Yang An, Lin Yuan, Zhi-Yang Liu, Zhong-Liang Du, Ke-Ming Zheng, Zhong-Zheng |
author_sort | Li, Ye-Mo |
collection | PubMed |
description | The function of natural killer (NK) cells has previously been implicated in hematopoietic-related diseases. Killer immunoglobulin-like receptors (KIR) play an important role in NK cells after hematopoietic stem cell transplantation. To explore the immunogenetic predisposition of hematological-related diseases, herein, a multi-center retrospective study in China was conducted, analyzing and comparing 2519 patients with hematopathy (mainly, acute lymphoblastic leukemia, acute myeloid leukemia, aplastic anemia, and myelodysplastic syndrome) to 18,108 individuals without known pathology. Genotyping was performed by polymerase chain reaction with specific sequence primers (PCR-SSP). As a result, we discovered four genes including KIR2DL5 (OR: 0.74, 95% CI 0.59–0.93; Pc = 0.0405), 2DS1 (OR: 0.74, 95% CI 0.59–0.93; Pc = 0.0405), 2DS3 (OR: 0.58, 95% CI 0.41–0.81; Pc = 0.0180), and 3DS1 (OR: 0.74, 95% CI 0.58–0.94; Pc = 0.0405) to be protective factors that significantly reduce the risk of aplastic anemia. Our findings offer new approaches to immunotherapy for hematological-related diseases. As these therapies mature, they are promising to be used alone or in combination with current treatments to help to make blood disorders a manageable disease. |
format | Online Article Text |
id | pubmed-10276034 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-102760342023-06-18 Exploration of KIR genes and hematological-related diseases in Chinese Han population Li, Ye-Mo Li, Yu-Xia Hu, Xiao-Zhuang Li, Dai-Yang An, Lin Yuan, Zhi-Yang Liu, Zhong-Liang Du, Ke-Ming Zheng, Zhong-Zheng Sci Rep Article The function of natural killer (NK) cells has previously been implicated in hematopoietic-related diseases. Killer immunoglobulin-like receptors (KIR) play an important role in NK cells after hematopoietic stem cell transplantation. To explore the immunogenetic predisposition of hematological-related diseases, herein, a multi-center retrospective study in China was conducted, analyzing and comparing 2519 patients with hematopathy (mainly, acute lymphoblastic leukemia, acute myeloid leukemia, aplastic anemia, and myelodysplastic syndrome) to 18,108 individuals without known pathology. Genotyping was performed by polymerase chain reaction with specific sequence primers (PCR-SSP). As a result, we discovered four genes including KIR2DL5 (OR: 0.74, 95% CI 0.59–0.93; Pc = 0.0405), 2DS1 (OR: 0.74, 95% CI 0.59–0.93; Pc = 0.0405), 2DS3 (OR: 0.58, 95% CI 0.41–0.81; Pc = 0.0180), and 3DS1 (OR: 0.74, 95% CI 0.58–0.94; Pc = 0.0405) to be protective factors that significantly reduce the risk of aplastic anemia. Our findings offer new approaches to immunotherapy for hematological-related diseases. As these therapies mature, they are promising to be used alone or in combination with current treatments to help to make blood disorders a manageable disease. Nature Publishing Group UK 2023-06-16 /pmc/articles/PMC10276034/ /pubmed/37328612 http://dx.doi.org/10.1038/s41598-023-36882-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Li, Ye-Mo Li, Yu-Xia Hu, Xiao-Zhuang Li, Dai-Yang An, Lin Yuan, Zhi-Yang Liu, Zhong-Liang Du, Ke-Ming Zheng, Zhong-Zheng Exploration of KIR genes and hematological-related diseases in Chinese Han population |
title | Exploration of KIR genes and hematological-related diseases in Chinese Han population |
title_full | Exploration of KIR genes and hematological-related diseases in Chinese Han population |
title_fullStr | Exploration of KIR genes and hematological-related diseases in Chinese Han population |
title_full_unstemmed | Exploration of KIR genes and hematological-related diseases in Chinese Han population |
title_short | Exploration of KIR genes and hematological-related diseases in Chinese Han population |
title_sort | exploration of kir genes and hematological-related diseases in chinese han population |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276034/ https://www.ncbi.nlm.nih.gov/pubmed/37328612 http://dx.doi.org/10.1038/s41598-023-36882-y |
work_keys_str_mv | AT liyemo explorationofkirgenesandhematologicalrelateddiseasesinchinesehanpopulation AT liyuxia explorationofkirgenesandhematologicalrelateddiseasesinchinesehanpopulation AT huxiaozhuang explorationofkirgenesandhematologicalrelateddiseasesinchinesehanpopulation AT lidaiyang explorationofkirgenesandhematologicalrelateddiseasesinchinesehanpopulation AT anlin explorationofkirgenesandhematologicalrelateddiseasesinchinesehanpopulation AT yuanzhiyang explorationofkirgenesandhematologicalrelateddiseasesinchinesehanpopulation AT liuzhongliang explorationofkirgenesandhematologicalrelateddiseasesinchinesehanpopulation AT dukeming explorationofkirgenesandhematologicalrelateddiseasesinchinesehanpopulation AT zhengzhongzheng explorationofkirgenesandhematologicalrelateddiseasesinchinesehanpopulation |